Health In Tech, Inc. Class A Common Stock (HIT) — Capital Reinvestment Ratio

Latest as of December 2025: 1.84x

Health In Tech, Inc. Class A Common Stock (HIT) has a Capital Reinvestment Ratio of 1.84x as of December 2025, meaning it reinvests 2% of its operating cash flow ($451.21K) in capital expenditures ($831.71K). See Health In Tech, Inc. Class A Common Stoc (HIT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.84x
Capex / Operating Cash Flow

Operating Cash Flow

$451.21K
USD

Capital Expenditures

$831.71K
USD

Data as of

Dec 2025
Most recent filing

Health In Tech, Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)

This chart tracks Health In Tech, Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods.

Annual Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock (2022–2025)

Year-by-year Capital Reinvestment Ratio for Health In Tech, Inc. Class A Common Stock from 2022 to 2025. For live market cap and broader valuation context, see Health In Tech, Inc. Class A Common Stoc market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 1.02x $3.13 Million $3.19 Million ▲ +145.9%
2024 0.41x $2.18 Million $900.75K ▼ -44.7%
2023 0.75x $1.53 Million $1.14 Million ▼ -52.0%
2022 1.56x $782.75K $1.22 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow